Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q20707794> ?p ?o }
Showing triples 1 to 26 of
26
with 100 triples per page.
- Q20707794 subject Q5856563.
- Q20707794 subject Q7441579.
- Q20707794 subject Q8210723.
- Q20707794 abstract "AVN-101, a close structural analogue of latrepirdine, is a selective 5-HT6 receptor antagonist which is under development by Avineuro Pharmaceuticals for the treatment of Alzheimer's disease and anxiety disorders. As of November 2013, it is in phase II clinical trials for these indications.".
- Q20707794 wikiPageExternalLink 800030006.
- Q20707794 wikiPageExternalLink cns-platform.
- Q20707794 wikiPageExternalLink pipeline.
- Q20707794 wikiPageWikiLink Q11081.
- Q20707794 wikiPageWikiLink Q18027448.
- Q20707794 wikiPageWikiLink Q19596009.
- Q20707794 wikiPageWikiLink Q30612.
- Q20707794 wikiPageWikiLink Q408580.
- Q20707794 wikiPageWikiLink Q410943.
- Q20707794 wikiPageWikiLink Q485014.
- Q20707794 wikiPageWikiLink Q544006.
- Q20707794 wikiPageWikiLink Q5856563.
- Q20707794 wikiPageWikiLink Q7180990.
- Q20707794 wikiPageWikiLink Q7441579.
- Q20707794 wikiPageWikiLink Q8210723.
- Q20707794 type ChemicalSubstance.
- Q20707794 type Drug.
- Q20707794 type ChemicalObject.
- Q20707794 type Thing.
- Q20707794 type Q8386.
- Q20707794 comment "AVN-101, a close structural analogue of latrepirdine, is a selective 5-HT6 receptor antagonist which is under development by Avineuro Pharmaceuticals for the treatment of Alzheimer's disease and anxiety disorders. As of November 2013, it is in phase II clinical trials for these indications.".
- Q20707794 label "AVN-101".